Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: David Israel-Rosen who wrote (1440)	10/18/1998 2:57:00 PM
From: tom pope	Read Replies (2) \| Respond to of 1491

When does PARS report? Apologies if this has already been posted. TIA

To: David Israel-Rosen who wrote (1440)	10/18/1998 6:41:00 PM
From: Shlepper	Read Replies (2) \| Respond to of 1491

David, What are the chances of expedited use of HU-211 in Israel? Since there are tests ongoing in Israel and safety has already been proven, is it unreasonable for the drug to be marketed early - since there is no other comparable drug on the market? I enjoy and appreciate your excitement. I'll be in Israel this winter or spring and hope to visit PARS. By the sound of your optimism, perhaps I'll be able to buy in Jerusalem :>L